| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e0bf0928b608797b70bbc2b91c7e52e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-22 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2012-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa13ff8489b6e6af9df6138efeac5dae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4ffca13622ae25827f2b03c2b1d1180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdc82e22caa599ff622ffff8a91eb9b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2601af3f84b011d7d0308667a52da0ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbce03e178eb7eb223a443d8d760ade6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2308e487f12f097b6a2151834b16c0f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6844389c8980a6436e8f0178068ed03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52969218bb1fb7b0452a392883a07fb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b5b3cc2bdf62a36e24157ad6d753271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca3bf557312e02a0e120bc9908149b2a |
| publicationDate |
2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015037825-A1 |
| titleOfInvention |
Means and Methods for Assessing Hematopoietic Toxicity |
| abstract |
The present invention pertains to the field of diagnostics for hematopoietic toxicity and toxicological assessments for risk stratification of chemical compounds. Specifically, it relates to a method for diagnosing hematopoietic toxicity. It also relates to a method for determining whether a compound is capable of inducing such hematopoietic toxicity in a subject and to a method of identifying a drug for treating hematopoietic toxicity. Furthermore, the present invention relates to a device and a kit for diagnosing hematopoietic toxicity. |
| priorityDate |
2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |